Poor treatment outcomes and associated factors among epileptic patients at Ambo Hospital, Ethiopia
Etiyopya Ambo Hastanesi’nde epilepsi hastalarında kötü tedavi sonuçları ve ilişkili faktörler
Abstract views: 454 / PDF downloads: 289
DOI:
https://doi.org/10.5455/GMJ-30-163442Keywords:
Epilepsy, seizure, treatment outcome, Ambo HospitalAbstract
Approximately one third of patients with epilepsy continue to experience seizure despite the prescription of appropriate doses of anti-epileptic drugs. The objective of this study was to assess treatment outcomes and associated factors for poor treatment outcomes among patients taking anti-epileptic drugs at Ambo Hospital, West Shewa, Ethiopia. A hospital based cross–sectional study was conducted. Verbal consent from participants was taken before interview. Fifty-nine patients (44.7%) had poor seizure control. The most common seizure triggering factors were emotional stress (97.4%), sleep deprivation (78.1%), missing meal (29.8%)and missing medication (21.9%). Seventy one patients (53.8%) were non-adherent to medication. Therefore there is significant association between level of adherence (P=0.001), number of seizure attacks before anti-epileptic drugs initiation (p=0.028), electroencephalogram(neurologic abnormality) (p=0.04) and age at onset of seizure (diagnosis) (p=0.026). Poor treatment outcomes among epileptic patients is associated with level of adherence, number of seizure attacks before anti-epileptic drugs initiations, electroencephalogram(neurologic abnormality) and age at onset of seizure (diagnosis). The most common seizure triggering factors were emotional distress, sleep deprivation, missing meal, missing medication and noise. Strict medication adherence evaluation and enhancement through continues health education, close follow up with multidisciplinary approach are fundamental to the successful management of epileptic patients.
Metrics
References
World Health Organization. Epilepsy: epidemiology, etiology and prognosis. 2001, Geneva (WHO Fact Sheet No 165; available on the Internet at, http://www.who.int/inffs/en/fact165.html). Accessed at December 20, 2013.
Babaei A, Eslamai MH. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients. International journal of clinical pharmacology and therapeutics. 2007 Feb;45(2):121-5. PubMed PMID: 17323792. Epub 2007/02/28. eng.
Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, et al. Clinical effectiveness, tolerability and cost effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health technology assessment (Winchester, England). 2005 Apr;9(15):1-157, iii-iv. PubMed PMID: 15842952. Epub 2005/04/22. eng.
Liu L, Yiu CH, Yen DJ, Chou MH, Lin MF. Medication education for patients with epilepsy in Taiwan. Seizure : the journal of the British Epilepsy Association. 2003 Oct;12(7):473-7. PubMed PMID: 12967575. Epub 2003/09/12. eng.
Adamolekun B, Mielke JK, Ball DE. An evaluation of the impact of health worker and patient education on the care and compliance of patients with epilepsy in Zimbabwe. Epilepsia. 1999 Apr;40(4):507-11. PubMed PMID: 10219280. Epub 1999/04/29. eng.
Jones RM, Butler JA, Thomas VA, Peveler RC, Prevett M. Adherence to treatment in patients with epilepsy: Associations with seizure control and illness beliefs. Seizure - European Journal of Epilepsy.15(7):504-8.
Leppik IE. How to get patients with epilepsy to take their medication. The problem of noncompliance. Postgraduate medicine. 1990 Jul;88(1):253-6. PubMed PMID: 2367256. Epub 1990/07/01. eng.
Carpay JA, Aldenkamp AP, van Donselaar CA. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure : the journal of the British Epilepsy Association. 2005 Apr;14(3):198-206. PubMed PMID: 15797355. Epub 2005/03/31. eng.
Seneviratne U, Rajapakse P, Pathirana R, Seetha T. Knowledge, attitude, and practice of epilepsy in rural Sri Lanka. Seizure : the journal of the British Epilepsy Association. 2002 Jan;11(1):40-3. PubMed PMID: 11888258. Epub 2002/03/13. eng.
Buchanan N. Noncompliance with medication amongst persons attending a tertiary referral epilepsy clinic: implications, management and outcome. Seizure : the journal of the British Epilepsy Association. 1993 Mar;2(1):79-82. PubMed PMID: 8162379. Epub 1993/03/01. eng.
Crump SR, Mayberry RM, Taylor BD, Barefield KP, Thomas PE. Factors related to noncompliance with screening mammogram appointments among low-income African American women. Journal of the National Medical Association. 2000 May;92(5):237-46. PubMed PMID: 10881473. Pubmed Central PMCID: PMC2640573. Epub 2000/07/06. eng.
Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophrenia research. 2003 Sep 1;63(1-2):49-58. PubMed PMID: 12892857. Epub 2003/08/02. eng.
Yiannakopoulou E, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: a critical factor for blood pressure control. European journal of cardiovascular prevention andrehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 2005 Jun;12(3):243-9. PubMed PMID: 15942423. Epub 2005/06/09. eng.
Pinikahana J, Dono J. The lived experience of initial symptoms of and factors triggering epileptic seizures. Epilepsy & behavior : E&B. 2009 Aug;15(4):513-20. PubMed PMID: 19559655. Epub 2009/06/30. eng.
Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. Journal of clinical epidemiology. 2001 Dec;54 Suppl 1:S57-60. PubMed PMID: 11750211. Epub 2001/12/26. eng.
Balamurugan E, Aggarwal M, Lamba A, Dang N, Tripathi M. Perceived trigger factors of seizures in persons with epilepsy. Seizure : the journal of the British Epilepsy Association. 2013 Nov;22(9):743-7. PubMed PMID: 23806632. Epub 2013/06/29. eng.
Report prepared for the World Health Organization. Sodium valproate in childhood epilepsy.November 2006 available on http://archives.who.int/eml/expcom/expcom15/applications/paediatrics/formulations/Sodiumvalproate.pdf. (Accessed on May 2014).
Buck.D. Factors influencing compliance with antiepileptic drug regimes. Centre for Health Services Research University of Newcastle-upon Tyne, Walton Hospital, Liverpool UK, 2003; 21:74-75.
Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman medical journal. 2011 May;26(3):155-9. PubMed PMID: 22043406. Pubmed Central PMCID: PMC3191684. Epub 2011/11/02. eng.
Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Social science & medicine (1982). 1992 Mar;34(5):507-13. PubMed PMID: 1604357. Epub 1992/03/01. eng.
Liu.J, Liu.Z, Ding.H, Yang.X.Adherence to treatment and influencing factors in a sample of Chinese epilepsy patients. Pub Med; November 25, 2012; to May 29, 2013; 72-74.
Yach .D. Adherence to long term therapies evidence for action, WHO; 2003, fact sheet 165, 87-94.
Pati S, Alexopoulos AV. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies. Cleveland Clinic journal of medicine. 2010 Jul;77(7):457-67. PubMed PMID: 20601619. Epub 2010/07/06. eng.
Johnbull.O1, Farounbi.B2, Ademola .O et al. Evaluation of Factors Influencing Medication Adherence in Patients with Epilepsy in Rural Communities of Kaduna State, Nigeria.2002; 45:1847-56.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.